Reviewed by the Metago Health Clinical Team | Evidence updated to reflect the latest published clinical data Key Takeaways Semaglutide
Medically reviewed against IDF, AHA/NHLBI, and ICMR clinical guidance Key TakeawaysMetabolic syndrome is a cluster of 3 of 5 warning
Evidence-based clinical overview · Reviewed against peer-reviewed trials and Indian obesity guidelines Last updated: June 2026 Key TakeawaysThere is no
Written by the Editorial Team | Medically reviewed by a qualified physician | Last updated June 1, 2026 Key TakeawaysGLP-1
Evidence-based health guide | Reviewed against current peer-reviewed medical literature | Last updated: May 2026 KEY TAKEAWAYSThere is no direct
Evidence-based guide | Reviewed against current clinical research | Last updated: May 2026 Key TakeawaysBoth Ozempic (semaglutide) and Mounjaro (tirzepatide)
Medically reviewed by [Add reviewing endocrinologist or bariatric surgeon, with credentials] | Last updated: May 2026 Key TakeawaysGLP-1 injections (Mounjaro,
Evidence-based guide • Reviewed against peer-reviewed studies and official guidelines • Updated May 2026 Key TakeawaysHidden causes stall weight loss:
A deep dive into one of India’s fastest-growing metabolic epidemics, and the science-backed strategies that can help reverse it. Insulin
Key TakeawaysA weight loss plateau occurs when your body adapts to fewer calories, causing your resting metabolic rate to slow
